Go to
JCI Insight
Citations to this article
Jacob K. Files, … , Paul A. Goepfert, Nathan Erdmann
Published October 29, 2020
Citation Information: J Clin Invest. 2021;131(1):e140491. https://doi.org/10.1172/JCI140491.
Citation Information: J Clin Invest. 2021;131(1):e140491. https://doi.org/10.1172/JCI140491.
Abstract
SARS-CoV-2 causes a wide spectrum of clinical manifestations and significant mortality. Studies investigating underlying immune characteristics are needed to understand disease pathogenesis and inform vaccine design. In this study, we examined immune cell subsets in hospitalized and nonhospitalized individuals. In hospitalized patients, many adaptive and innate immune cells were decreased in frequency compared with those of healthy and convalescent individuals, with the exception of an increase in B lymphocytes. Our findings show increased frequencies of T cell activation markers (CD69, OX40, HLA-DR, and CD154) in hospitalized patients, with other T cell activation/exhaustion markers (PD-L1 and TIGIT) remaining elevated in hospitalized and nonhospitalized individuals. B cells had a similar pattern of activation/exhaustion, with increased frequency of CD69 and CD95 during hospitalization followed by an increase in PD1 frequencies in nonhospitalized individuals. Interestingly, many of these changes were found to increase over time in nonhospitalized longitudinal samples, suggesting a prolonged period of immune dysregulation after SARS-CoV-2 infection. Changes in T cell activation/exhaustion in nonhospitalized patients were found to positively correlate with age. Severely infected individuals had increased expression of activation and exhaustion markers. These data suggest a prolonged period of immune dysregulation after SARS-CoV-2 infection, highlighting the need for additional studies investigating immune dysregulation in convalescent individuals.
Authors
Jacob K. Files, Sushma Boppana, Mildred D. Perez, Sanghita Sarkar, Kelsey E. Lowman, Kai Qin, Sarah Sterrett, Eric Carlin, Anju Bansal, Steffanie Sabbaj, Dustin M. Long, Olaf Kutsch, James Kobie, Paul A. Goepfert, Nathan Erdmann
Total citations by year
Citation information
Citations to this article (82)
| Title and authors | Publication | Year |
|---|---|---|
|
Potential Biomarkers for Predicting the Risk of Developing Into Long COVID After COVID‐19 Infection
Hou Z, Ming Y, Liu J, Wang Z |
Immunity, Inflammation and Disease | 2025 |
|
Increased antibody titres but exhausted dynamic T-cell response in COVID-19 convalescents by inactivated vaccine booster
Jingmin Zhao, Han Zhang, Lina Jiang, Fang Cheng, Wei Li, Zihao Wang, Hongyang Liu, Shaohua Li, Yiyun Jiang, Meiling Li, Yan Li, Shuhong Liu, Min Fang, Xuyu Zhou, Xin Ye, Shousong Zhao, Yuxuan Zheng, Songdong Meng |
Microbiology spectrum | 2024 |
|
Non-fatal outcomes of COVID-19 disease in pediatric organ transplantation associates with down-regulation of senescence pathways.
Kumar Subramanian, Rency Varghese, Molly Pochedly, Vinona Muralidaran, Nada Yazigi, Stuart Kaufman, Khalid Khan, Bernadette Vitola, Alexander Kroemer, Thomas M Fishbein, Habtom Ressom, Udeme D Ekong |
Scientific Reports | 2024 |
|
Adaptive immune cells are necessary for SARS-CoV-2–induced pathology
Imbiakha B, Sahler JM, Buchholz DW, Ezzatpour S, Jager M, Choi A, Monreal IA, Byun H, Adeleke RA, Leach J, Whittaker G, Dewhurst S, Rudd BD, Aguilar HC, August A |
Science Advances | 2024 |
|
Autoimmunity and long COVID in children
Boyarchuk O, Volianska L |
2024 | |
|
Immune Responses in Discharged COVID-19 Patients With and Without Long COVID Symptoms.
Wang Y, Guo L, Cui D, Zhang H, Zhang Q, Ren L, Wang G, Zhang X, Huang T, Chen L, Huang L, Wang X, Zhong J, Wang Y, Li H, Wang J, Cao B |
Open Forum Infectious Diseases | 2024 |
|
High frequencies of alpha common cold coronavirus/SARS-CoV-2 cross-reactive functional CD4(+) and CD8(+) memory T cells are associated with protection from symptomatic and fatal SARS-CoV-2 infections in unvaccinated COVID-19 patients.
Coulon PG, Prakash S, Dhanushkodi NR, Srivastava R, Zayou L, Tifrea DF, Edwards RA, Figueroa CJ, Schubl SD, Hsieh L, Nesburn AB, Kuppermann BD, Bahraoui E, Vahed H, Gil D, Jones TM, Ulmer JB, BenMohamed L |
Frontiers in immunology | 2024 |
|
Impact of Chronic HIV Infection on Acute Immune Responses to SARS-CoV-2
Opsteen S, Fram T, Files JK, Levitan EB, Goepfert P, Erdmann N |
Journal of acquired immune deficiency syndromes (1999) | 2024 |
|
TIGIT Regulates T Cell Inflammation in Airway Inflammatory Diseases.
Ke J, Huang S, He Z, Lei S, Lin S, Duan M |
Inflammation | 2024 |
|
Multidisciplinary Management Strategies for Long COVID: A Narrative Review.
Prusinski C, Yan D, Klasova J, McVeigh KH, Shah SZ, Fermo OP, Kubrova E, Farr EM, Williams LC, Gerardo-Manrique G, Bergquist TF, Pham SM, Engelberg-Cook E, Hare JM, March KL, Caplan AI, Qu W |
Cureus | 2024 |
|
Accelerated tumor progression after COVID-19 infection in patients with glioblastoma: A retrospective case–control study
Gregory TA, Knight SR, Aaroe AE, Highsmith KN, Janatpour ZC, O\u2019Brien BJ, Majd NK, Loghin ME, Patel CB, Weathers SP, Puduvalli VK, Kamiya-Matsuoka C |
Neuro-Oncology Practice | 2024 |
|
Relationship between acute SARS-CoV-2 viral clearance with Long COVID Symptoms: a cohort study
Herbert C, Antar AA, Broach J, Wright C, Stamegna P, Luzuriaga K, Hafer N, McManus DD, Manabe YC, Soni A |
2024 | |
|
Immune-Enhancing Effects of Gwakhyangjeonggi-san in RAW 264.7 Macrophage Cells through the MAPK/NF-κB Signaling Pathways
Jeong YH, Yang HJ, Li W, Oh YC, Choi JG |
International Journal of Molecular Sciences | 2024 |
|
Identifying immune checkpoints on dysregulated T-cells as prognostic biomarkers for multiple myeloma patients with COVID-19
Li Z, He H, Zhang F, Li H, Jin X, Song Y, Liu S, Wang X, Zhuang J |
Frontiers in Immunology | 2024 |
|
Relationship Between Acute SARS-CoV-2 Viral Clearance and Long COVID-19 (Long COVID) Symptoms: A Cohort Study
Herbert C, Antar AA, Broach J, Wright C, Stamegna P, Luzuriaga K, Hafer N, McManus DD, Manabe YC, Soni A |
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America | 2024 |
|
Understanding immunity: an alternative framework beyond defense and strength
Zach M, Greslehner GP |
Biology & Philosophy | 2023 |
|
The role of immune activation and antigen persistence in acute and long COVID.
Opsteen S, Files JK, Fram T, Erdmann N |
Journal of investigative medicine : the official publication of the American Federation for Clinical Research | 2023 |
|
Encephalic nocardiosis after mild COVID-19: A case report
Bouhamdani N, Comeau D, Bourque C, Saulnier N |
Frontiers in neurology | 2023 |
|
Viral persistence, reactivation, and mechanisms of long COVID.
Chen B, Julg B, Mohandas S, Bradfute SB |
eLife | 2023 |
|
Long COVID: Clinical characteristics, proposed pathogenesis and potential therapeutic targets
Kenny G, Townsend L, Savinelli S, Mallon PW |
Frontiers in Molecular Biosciences | 2023 |
|
Interferon at the crossroads of SARS-CoV-2 infection and COVID-19 disease
Samuel CE |
The Journal of biological chemistry | 2023 |
|
Why has the epidemiology of RSV changed during the COVID-19 pandemic?
Abu-Raya B, Viñeta Paramo M, Reicherz F, Lavoie PM |
2023 | |
|
Extracellular vesicles in COVID-19 convalescence can regulate T cell metabolism and function
George MS, Sanchez J, Rollings C, Fear D, Irving P, Sinclair LV, Schurich A |
iScience | 2023 |
|
Post-COVID symptoms are associated with endotypes reflecting poor inflammatory and hemostatic modulation
An AY, Baghela A, Zhang PG, Blimkie TM, Gauthier J, Kaufmann DE, Acton E, Lee AH, Levesque RC, Hancock RE |
Frontiers in immunology | 2023 |
|
Accelerated Longitudinal Weight Gain Among Infants With In Utero COVID-19 Exposure.
Ockene MW, Russo SC, Lee H, Monthé-Drèze C, Stanley TL, Ma IL, Toribio M, Shook LL, Grinspoon SK, Edlow AG, Fourman LT |
The Journal of clinical endocrinology and metabolism | 2023 |
|
Pulmonary nocardiosis following COVID-19 in a patient with idiopathic pulmonary fibrosis and lung transplantation: a case report
Cao L, Sun Y, Chen F |
Frontiers in Medicine | 2023 |
|
Reshaping Our Knowledge: Advancements in Understanding the Immune Response to Human Respiratory Syncytial Virus
Attaianese F, Guiducci S, Trapani S, Barbati F, Lodi L, Indolfi G, Azzari C, Ricci S |
Pathogens | 2023 |
|
A myeloid program associated with COVID-19 severity is decreased by therapeutic blockade of IL-6 signaling
Hackney JA, Shivram H, Vander Heiden J, Overall C, Orozco L, Gao X, Kim E, West N, Qamra A, Chang D, Chakrabarti A, Choy DF, Combes AJ, Courau T, Fragiadakis GK, Rao AA, Ray A, Tsui J, Hu K, Kuhn NF, Krummel MF, Erle DJ, Kangelaris K, Sarma A, Lyon Z, Calfee CS, Woodruff PG, Ghale R, Mick E, Byrne A, Zha BS, Langelier C, Hendrickson CM, van der Wijst MG, Hartoularos GC, Grant T, Bueno R, Lee DS, Greenland JR, Sun Y, Perez R, Ogorodnikov A, Ward A, Ye CJ, Ramalingam T, McBride JM, Cai F, Teterina A, Bao M, Tsai L, Rosas IO, Regev A, Kapadia SB, Bauer RN, Rosenberger CM |
iScience | 2023 |
|
Mucormycosis in COVID-19 patients: A cross-sectional study at IGIMS, Patna
Yasmeen T, Prasad N, Kumar V, Sinha S, Kumar S, Kumar S |
Journal of Family Medicine and Primary Care | 2023 |
|
Gut Microbiota and Mitochondria: Health and Pathophysiological Aspects of Long COVID.
Ailioaie LM, Ailioaie C, Litscher G |
International journal of molecular sciences | 2023 |
|
Proteomic profiling identifies biomarkers of COVID-19 severity
Harriott NC, Ryan AL |
Heliyon | 2023 |
|
Functional reprogramming of monocytes in acute and convalescent severe COVID-19 patients
Elisa Brauns, Abdulkader Azouz, David Grimaldi, Hanxi Xiao, Séverine Thomas, Muriel Nguyen, Véronique Olislagers, Ines Vu Duc, Carmen Orte Cano, Véronique Del Marmol, Pieter Pannus, Frédérick Libert, Sven Saussez, Nicolas Dauby, Jishnu Das, Arnaud Marchant, Stanislas Goriely |
JCI Insight | 2022 |
|
Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection
F Ryan, C Hope, M Masavuli, M Lynn, Z Mekonnen, A Yeow, P Garcia-Valtanen, Z Al-Delfi, J Gummow, C Ferguson, S OConnor, B Reddi, P Hissaria, D Shaw, C Kok-Lim, J Gleadle, M Beard, S Barry, B Grubor-Bauk, D Lynn |
BMC Medicine | 2022 |
|
Cellular metabolic basis of altered immunity in the lungs of patients with COVID-19
S Li, F Zhao, J Ye, K Li, Q Wang, Z Du, Q Yue, S Wang, Q Wu, H Chen |
Medical Microbiology and Immunology | 2022 |
|
SBT (Composed of Panax ginseng and Aconitum carmichaeli) and Stigmasterol Enhances Nitric Oxide Production and Exerts Curative Properties as a Potential Anti-Oxidant and Immunity-Enhancing Agent
N Han, K Kim, J Kim, H Park, S Ko, P Moon |
Antioxidants | 2022 |
|
Robust, persistent adaptive immune responses to SARS-CoV-2 in the oropharyngeal lymphoid tissue of children
Kalpana Manthiram, Qin Xu, Pedro Milanez-Almeida, Andrew Martins, Andrea Radtke, Kenneth Hoehn, Jinguo Chen, Can Liu, Juanjie Tang, Gabrielle Grubbs, Sydney Stein, Sabrina Ramelli, Juraj Kabat, Hengameh Behzadpour, Maria Karkanitsa, Jacquelyn Spathies, Heather Kalish, Lela Kardava, Martha Kirby, Foo Cheung, Silvia Preite, Patrick Duncker, Nahir Romero, Diego Preciado, Lyuba Gitman, Galina Koroleva, Grace Smith, Arthur Shaffer, Ian McBain, Stefania Pittaluga, Ronald Germain, Richard Apps, Kaitlyn Sadtler, Susan Moir, Daniel Chertow, Steven Kleinstein, Surender Khurana, John Tsang, Pamela Mudd, Pamela Schwartzberg |
Research square | 2022 |
|
Chemokines, soluble PD-L1, and immune cell hyporesponsiveness are distinct features of SARS-CoV-2 critical illness
Morrell ED, Bhatraju PK, Sathe NA, Lawson J, Mabrey L, Holton SE, Presnell SR, Wiedeman A, Acosta-Vega C, Mitchem MA, Liu T, Chai XY, Sahi S, Brager C, Orlov M, Sakr SS, Sader A, Lum DM, Koetje N, Garay A, Barnes E, Cromer G, Bray MK, Pipavath S, Fink SL, Evans L, Long SA, West TE, Wurfel MM, Mikacenic C |
AJP Lung Cellular and Molecular Physiology | 2022 |
|
Remodeling of T Cell Dynamics During Long COVID Is Dependent on Severity of SARS-CoV-2 Infection
Wiech M, Chroscicki P, Swatler J, Stepnik D, De Biasi S, Hampel M, Brewinska-Olchowik M, Maliszewska A, Sklinda K, Durlik M, Wierzba W, Cossarizza A, Piwocka K |
Frontiers in immunology | 2022 |
|
Immunological memory to SARS-CoV-2 infection and COVID-19 vaccines.
Sette A, Crotty S |
Immunological Reviews | 2022 |
|
COVID‐19 rapidly increases MDSCs and prolongs innate immune dysfunctions
Schrijver IT, Théroude C, Antonakos N, Regina J, Le Roy D, Bart P, Chiche J, Perreau M, Pantaleo G, Calandra T, Roger T |
European Journal of Immunology | 2022 |
|
COVID-19 associated multisystemic mucormycosis from India: a multicentric retrospective study on clinical profile, predisposing factors, cumulative mortality and factors affecting outcome.
Sahu M, Shah M, Mallela VR, Kola VR, Boorugu HK, Punjani AAR, Kumar RV, Kumar S, Manusrut M, Kumar SCR, Rathod R, Babu DM, Gonuguntla HK, Yedlapati GK, Mallu GR, Reddy YS, Reddy VV, Alwala S, Bongu VK, Kamalesh A, Kumar RNK, Jaishetwar GS, Bagapally RS, Srinivas JS, Balasubramaniam A, Rajagopalan BK, Pullikanti B, Prakasham SP, Nimmala P, Nagaraju B, Sahoo PR |
Infection | 2022 |
|
Covid-19 and Mucormycosis Superinfection: Prospective, Obsevational Study in a Single Center.
Garg S, Masheshwari D, Bhushan B, Sardana V, Jain RK |
Annals of Indian Academy of Neurology | 2022 |
|
Recovering or Persisting: The Immunopathological Features of SARS-CoV-2 Infection in Children
Buonsenso D, Valentini P, De Rose C, Tredicine M, Pereyra Boza MD, Camponeschi C, Morello R, Zampino G, Brooks AE, Rende M, Ria F, Sanguinetti M, Delogu G, Sali M, Di Sante G |
Journal of Clinical Medicine | 2022 |
|
Host and microbiome features of secondary infections in lethal covid-19.
Zacharias M, Kashofer K, Wurm P, Regitnig P, Schütte M, Neger M, Ehmann S, Marsh LM, Kwapiszewska G, Loibner M, Birnhuber A, Leitner E, Thüringer A, Winter E, Sauer S, Pollheimer MJ, Vagena FR, Lackner C, Jelusic B, Ogilvie L, Durdevic M, Timmermann B, Lehrach H, Zatloukal K, Gorkiewicz G |
iScience | 2022 |
|
Immunologic phenotype of patients with long-COVID syndrome of 1-year duration
García-Abellán J, Fernández M, Padilla S, García JA, Agulló V, Lozano V, Ena N, García-Sánchez L, Gutiérrez F, Masiá M |
Frontiers in immunology | 2022 |
|
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19
Ripa M, Galli L, D\u2019Angelo A, Apruzzi L, Palumbo D, Campochiaro C, Tassan Din C, Danise A, Da Prat V, Vitali G, Brugliera L, Poli A, Monardo R, Monti G, Baccellieri D, De Cobelli F, Clementi M, Iannaccone S, Dagna L, Rovere-Querini P, Ciceri F, Tresoldi M, Zangrillo A, Scarpellini P, Castagna A |
Open Forum Infectious Diseases | 2022 |
|
Pathogenesis and Pathology of COVID-Associated Mucormycosis: What Is New and Why
Radotra B, Challa S |
Current Fungal Infection Reports | 2022 |
|
Narrative review on century of respiratory pandemics from Spanish flu to COVID-19 and impact of nanotechnology on COVID-19 diagnosis and immune system boosting.
Elkhatib WF, Abdelkareem SS, Khalaf WS, Shahin MI, Elfadil D, Alhazmi A, El-Batal AI, El-Sayyad GS |
Virology Journal | 2022 |
|
The Challenge of Long COVID-19 Management: From Disease Molecular Hallmarks to the Proposal of Exercise as Therapy.
Scurati R, Papini N, Giussani P, Alberti G, Tringali C |
International journal of molecular sciences | 2022 |
|
Immune checkpoint alterations and their blockade in COVID-19 patients.
Tan J, Li Y |
2022 | |
|
Impaired adaptive immune response in COVID‐19 convalescent patients with hematological malignancies
Kalicińska E, Szymczak D, Andrasiak I, Milanowska A, Kiraga A, Majeranowski A, Jabłonowska P, Rybka J, Maciej Z, Wróbel T |
European Journal of Haematology | 2022 |
|
Adaptive immune responses to SARS-CoV-2 persist in the pharyngeal lymphoid tissue of children
Xu Q, Milanez-Almeida P, Martins AJ, Radtke AJ, Hoehn KB, Oguz C, Chen J, Liu C, Tang J, Grubbs G, Stein S, Ramelli S, Kabat J, Behzadpour H, Karkanitsa M, Spathies J, Kalish H, Kardava L, Kirby M, Cheung F, Preite S, Duncker PC, Kitakule MM, Romero N, Preciado D, Gitman L, Koroleva G, Smith G, Shaffer A, McBain IT, McGuire PJ, Pittaluga S, Germain RN, Apps R, Schwartz DM, Sadtler K, Moir S, Chertow DS, Kleinstein SH, Khurana S, Tsang JS, Mudd P, Schwartzberg PL, Manthiram K |
Nature Immunology | 2022 |
|
Prolonged adaptive immune activation in COVID-19: implications for maintenance of long-term immunity?
Philip A. Mudd, Kenneth E. Remy |
Journal of Clinical Investigation | 2021 |
|
Duration of post-COVID-19 symptoms are associated with sustained SARS-CoV-2 specific immune responses
Jacob K Files, Sanghita Sarkar, Timothy R Fram, Sushma Boppana, Sarah Sterrett, Kai Qin, Anju Bansal, Dustin M. Long, Steffanie Sabbaj, James J Kobie, Paul Goepfert, Nathan Erdmann |
JCI Insight | 2021 |
|
Longitudinal Analysis of COVID-19 Patients Shows Age-Associated T Cell Changes Independent of Ongoing Ill-Health
L Townsend, AH Dyer, A Naughton, R Kiersey, D Holden, M Gardiner, J Dowds, K OBrien, C Bannan, P Nadarajan, J Dunne, I Martin-Loeches, PG Fallon, C Bergin, C OFarrelly, CN Cheallaigh, NM Bourke, N Conlon |
Frontiers in immunology | 2021 |
|
Inefficient Placental Virus Replication and Absence of Neonatal Cell-Specific Immunity Upon Sars-CoV-2 Infection During Pregnancy
AC Tallarek, C Urbschat, LF Brito, S Stanelle-Bertram, S Krasemann, G Frascaroli, K Thiele, A Wieczorek, N Felber, M Lütgehetmann, UR Markert, K Hecher, W Brune, F Stahl, G Gabriel, A Diemert, PC Arck |
Frontiers in immunology | 2021 |
|
Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World
V Muthu, SM Rudramurthy, A Chakrabarti, R Agarwal |
Mycopathologia | 2021 |
|
SARS-CoV-2 Portrayed against HIV: Contrary Viral Strategies in Similar Disguise
R Duerr, KM Crosse, AM Valero-Jimenez, M Dittmann |
Microorganisms | 2021 |
|
COVID-19 and the human innate immune system
JL Schultze, AC Aschenbrenner |
Cell | 2021 |
|
Involvement of Interleukin-1 Receptor-Associated Kinase 4 and Interferon Regulatory Factor 5 in the Immunopathogenesis of SARS-CoV-2 Infection: Implications for the Treatment of COVID-19
N Stoy |
Frontiers in immunology | 2021 |
|
SARS-CoV-2-specific circulating T follicular helper cells correlate with neutralizing antibodies and increase during early convalescence
S Boppana, K Qin, JK Files, RM Russell, R Stoltz, F Bibollet-Ruche, A Bansal, N Erdmann, BH Hahn, PA Goepfert, PG Thomas |
PLoS pathogens | 2021 |
|
Could targeting immunometabolism be a way to control the burden of COVID-19 infection?
E Berber, D Sumbria, BT Rouse |
Microbes and infection / Institut Pasteur | 2021 |
|
Comprehensive Immunologic Evaluation of Bronchoalveolar Lavage Samples from Human Patients with Moderate and Severe Seasonal Influenza and Severe COVID-19
D Reynolds, CV Guillamet, A Day, N Borcherding, RV Guillamet, JA Choreño-Parra, SL House, JA OHalloran, J Zúñiga, AH Ellebedy, DE Byers, PA Mudd |
Journal of immunology (Baltimore, Md. : 1950) | 2021 |
|
Post‐surgical pyoderma gangrenosum in otherwise healthy patient with history of COVID‐19
MD Rich, TJ Sorenson, W Schubert |
The Breast Journal | 2021 |
|
Asymptomatic and Mild SARS-CoV-2 Infections Elicit Lower Immune Activation and Higher Specific Neutralizing Antibodies in Children Than in Adults
MR Petrara, F Bonfante, P Costenaro, A Cantarutti, F Carmona, E Ruffoni, CD Chiara, M Zanchetta, L Barzon, D Donà, LD Dalt, A Bortolami, M Pagliari, M Plebani, P Rossi, N Cotugno, P Palma, C Giaquinto, AD Rossi |
Frontiers in immunology | 2021 |
|
Immunopathology and Immunosenescence, the Immunological Key Words of Severe COVID-19. Is There a Role for Stem Cell Transplantation?
ME Ligotti, F Pojero, G Accardi, A Aiello, C Caruso, G Duro, G Candore |
Frontiers in Cell and Developmental Biology | 2021 |
|
The Role of Immunogenetics in COVID-19
F Pojero, G Candore, C Caruso, DD Bona, DA Groneberg, ME Ligotti, G Accardi, A Aiello |
International journal of molecular sciences | 2021 |
|
Mutations of SARS-CoV-2 spike protein: Implications on immune evasion and vaccine-induced immunity
HM Mengist, AJ Kombe, D Mekonnen, A Abebaw, M Getachew, T Jin |
Seminars in Immunology | 2021 |
|
Case Report: Interferon- γ Rescues Monocytic Human Leukocyte Antigen Receptor (mHLA-DR) Function in a COVID-19 Patient With ARDS and Superinfection With Multiple MDR 4MRGN Bacterial Strains
C Grimm, S Dickel, J Grundmann, D Payen, J Schanz, AE Zautner, B Tampe, O Moerer, MS Winkler |
Frontiers in immunology | 2021 |
|
COVID-19 and risk of subsequent life-threatening secondary infections: a matched cohort study in UK Biobank
C Hou, Y Hu, H Yang, W Chen, Y Zeng, Z Ying, Y Hu, Y Sun, Y Qu, M Gottfreðsson, UA Valdimarsdóttir, H Song |
BMC Medicine | 2021 |
|
SARS‐CoV‐2 and lung injury: Dysregulation of immune response but not hyperimmune response as in “cytokine storm syndrome”
S Öcal |
The Clinical Respiratory Journal | 2021 |
|
Coronavirus Disease-Associated Mucormycosis from a Tertiary Care Hospital in India: A Case Series
Y Singh, V Ganesh, S Kumar, N Patel, R Aggarwala, KD Soni, A Trikha |
Cureus | 2021 |
|
Clinical and immunologic implications of COVID-19 in patients with melanoma and renal cell carcinoma receiving immune checkpoint inhibitors
B Switzer, J Haanen, PC Lorigan, I Puzanov, S Turajlic |
Journal for ImmunoTherapy of Cancer | 2021 |
|
Autoimmune- and complement-mediated hematologic condition recrudescence following SARS-CoV-2 vaccination
AJ Portuguese, C Sunga, R Kruse-Jarres, T Gernsheimer, J Abkowitz |
Blood Advances | 2021 |
|
Multicenter Epidemiologic Study of Coronavirus Disease–Associated Mucormycosis, India
A Patel, R Agarwal, SM Rudramurthy, M Shevkani, I Xess, R Sharma, J Savio, N Sethuraman, S Madan, P Shastri, D Thangaraju, R Marak, K Tadepalli, P Savaj, A Sunavala, N Gupta, T Singhal, V Muthu, A Chakrabarti |
Emerging infectious diseases | 2021 |
|
Polysaccharide of atractylodes macrocephala koidz activated T lymphocytes to alleviate cyclophosphamide-induced immunosuppression of geese through novel_mir2/CD28/AP-1 signal pathway
W Li, X Xiang, N Cao, W Chen, Y Tian, X Zhang, X Shen, D Jiang, D Xu, S Xu |
Poultry science | 2021 |
|
Distinct Characteristics of COVID-19 Infection in Children
X Han, X Li, Y Xiao, R Yang, Y Wang, X Wei |
Frontiers in Pediatrics | 2021 |
|
Peripheral Blood Mitochondrial DNA Levels Were Modulated by SARS-CoV-2 Infection Severity and Its Lessening Was Associated With Mortality Among Hospitalized Patients With COVID-19
JJ Valdés-Aguayo, I Garza-Veloz, JR Vargas-Rodríguez, MC Martinez-Vazquez, L Avila-Carrasco, S Bernal-Silva, C González-Fuentes, A Comas-García, DE Alvarado-Hernández, AS Centeno-Ramirez, IP Rodriguez-Sánchez, I Delgado-Enciso, ML Martinez-Fierro |
Frontiers in Cellular and Infection Microbiology | 2021 |
|
Glycoprotein Targeted CAR-NK Cells for the Treatment of SARS-CoV-2 Infection
I Christodoulou, R Rahnama, J Ravich, J Seo, S Zolov, A Marple, D Markovitz, C Bonifant |
Frontiers in immunology | 2021 |
|
Inhibitory Immune Checkpoint Molecules and Exhaustion of T cells in COVID-19
M Barnova, A Bobcakova, V Urdova, R Kosturiak, L Kapustova, D Dobrota, M Jesenak |
Physiological research / Academia Scientiarum Bohemoslovaca | 2021 |
|
SARS-CoV-2-specific peripheral T follicular helper cells correlate with neutralizing antibodies and increase during convalescence.
Boppana S, Qin K, Files JK, Russell RM, Stoltz R, Bibollet-Ruche F, Bansal A, Erdmann N, Hahn BH, Goepfert P |
medRxiv : the preprint server for health sciences | 2020 |
|
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)